NovaMedica, Venter Pharma deal

Venter granted NovaMedica exclusive rights to develop and commercialize Venter's lactose intolerance diagnostic, LacTEST, in the Commonwealth of Independent States (CIS). NovaMedica expects to launch the product in Russia in 2015. Venter markets LacTESTin Spain and Germany. NovaMedica declined to disclose financial details, and Venter could not be reached. ...